PillRx only · Ointment · Topical
Tacrolimus
Tacrolimus
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US8 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 24 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.844
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
4
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
206K
Rx · 2026 Q1
11.2M
Units dispensed
+29%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Accord Healthcare Inc. | unknown | 6 | SUPPLYING |
| E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | unknown | 6 | SUPPLYING |
| Padagis Israel Pharmaceuticals Ltd | unknown | 6 | SUPPLYING |
| Glenmark Pharmaceuticals Inc., USA | unknown | 6 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jul 11, 2022RECALLRecall (Class III): Tacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDC 68462-534-35…
Defective Container: Tube split from side seam — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA